Published in Int J Parasitol Drugs Drug Resist on March 02, 2012
Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis. (WIRMS-1) | NCT00630383
Worming our way closer to the clinic. Int J Parasitol Drugs Drug Resist (2012) 0.75
Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology (2005) 5.26
Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am J Gastroenterol (2003) 3.40
Trichuris suis ova therapy for allergic rhinitis: a randomized, double-blind, placebo-controlled clinical trial. J Allergy Clin Immunol (2009) 2.74
Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-β pathway. J Exp Med (2010) 2.54
Iatrogenic Trichuris suis infection in a patient with Crohn disease. Arch Pathol Lab Med (2006) 2.36
Helminth-derived immunomodulators: can understanding the worm produce the pill? Nat Rev Immunol (2010) 1.66
Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study. Mult Scler (2011) 1.34
Sourcing a chemical succession for cyclosporin from parasites and human pathogens. Drug Discov Today (2005) 0.89
Heligmosomoides polygyrus immunomodulatory factor (IMF), targets T-lymphocytes. Parasite Immunol (1998) 0.88
Tumor infiltrating regulatory T cells: tractable targets for immunotherapy. Int Rev Immunol (2010) 0.85
Parasitic worm therapy for allergy: is this incongruous or avant-garde medicine? Clin Exp Allergy (2011) 0.84
Trichuris suis might be effective in treating allergic rhinitis. J Allergy Clin Immunol (2010) 0.83
TIME management by medicinal larvae. Int Wound J (2015) 0.75